Lirequinil
Alternative Names: RO 413696Latest Information Update: 25 Jul 2006
At a glance
- Originator Roche
- Class
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Sleep disorders
Most Recent Events
- 25 Jul 2006 No development reported - Phase-I for Sleep disorders in Netherlands (PO)
- 25 Jul 2006 No development reported - Phase-II for Sleep disorders in Switzerland (PO)
- 18 May 2001 Phase-I clinical trials for Sleep disorders in Netherlands (PO)